However, this does not negate the role of peripheral CB1R in reversing obesity, since a globally acting CB1R blockade reduces body weight in obese but not in lean mice [33], and peripherally restricted CB1R antagonists ameliorate obesity and its related metabolic abnormalities in DIO mice [20], [21]. The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.